title: Role of PGF2alpha and oxytocin in parturition in the brushtail possum (Trichosurus vulpecula).
abstract: Maturation of the fetal pituitary and adrenal glands allows the secretion of cortisol, which in turn leads to an increase in prostaglandin and mesotocin production. The production of prostaglandin and mesotocin results in an increase in uterine contractions and initiates birth in marsupials. The major metabolite of PGF(2alpha), 13,14-dihydro-15-keto-prostaglandin F(2alpha) (PGFM), has been found in the plasma of the possum at the time of birth and administration of PGF(2alpha) to female possums induced the adoption of the birth position. Evidence that mesotocin is an integral hormone of birth in the tammar wallaby indicates that both PGF(2alpha) and mesotocin or oxytocin are required for marsupial birth. The presence of PGF(2alpha) receptors in the uterus and corpus luteum of the possum, and the in vitro uterine responsiveness to PGF(2alpha) or oxytocin, were examined. PGF(2alpha) receptors were not observed in possum uteri and the inability of PGF(2alpha) to cause contractions indicates that PGF(2alpha) is not involved directly in contraction of the uterus at parturition. The presence of oxytocin and mesotocin receptors in the uterus of possoms and the ability of oxytocin to induce uterine contraction in vitro supports the view that mesotocin is required for expulsion of the young from the uterus. Low numbers of PGF(2alpha) receptors were found in the possum corpus luteum at birth, indicating an involvement of PGF(2alpha) in regression of the corpus luteum.
authors.affiliation: Department of Anatomical Science, The School of Biomedical Science, The University of Queensland, Brisbane 4072, Australia.
authors.forename: C
authors.initials: C
authors.lastname: Veitch
authors.forename: L
authors.initials: L
authors.lastname: Brown
authors.forename: C
authors.initials: C
authors.lastname: Sernia
authors.forename: R T
authors.initials: RT
authors.lastname: Gemmell
mesh_terms: D000818:Animals; D003338:Corpus Luteum / Q000737:chemistry; D015237:Dinoprost / Q000494:pharmacology*; D005260:Female; D066298:In Vitro Techniques; D009893:Opossums / Q000502:physiology*; D010121:Oxytocin / Q000494:pharmacology*; D011247:Pregnancy; D011869:Radioligand Assay / Q000379:methods; D018045:Receptors, Oxytocin / Q000032:analysis; D011979:Receptors, Pituitary Hormone / Q000032:analysis; D011982:Receptors, Prostaglandin / Q000032:analysis; D014590:Uterine Contraction / Q000187:drug effects*; D014599:Uterus / Q000737:chemistry / Q000187:drug effects
chemical_list: D018045:Receptors, Oxytocin; D011979:Receptors, Pituitary Hormone; D011982:Receptors, Prostaglandin; C116046:mesotocin receptor; C034671:prostaglandin F2alpha receptor; D010121:Oxytocin; D015237:Dinoprost